Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis

被引:94
|
作者
Njock, Makon-Sebastien [1 ]
Guiot, Julien [2 ,3 ]
Henket, Monique A. [2 ,3 ]
Nivelles, Olivier [1 ]
Thiry, Marc [4 ]
Dequiedt, Franck [5 ]
Corhay, Jean-Louis [2 ,3 ]
Louis, Renaud E. [2 ,3 ]
Struman, Ingrid [1 ]
机构
[1] Univ Liege, Lab Mol Angiogenesis, GIGA R, Liege, Belgium
[2] CHU Liege, Pneumol Dept, Liege, Belgium
[3] Univ Liege, Lab Pneumol, GIGA I3, Liege, Belgium
[4] Univ Liege, Lab Biol Cellulaire & Tissulaire, GIGA R, Liege, Belgium
[5] Univ Liege, Lab Signalisat & Interact Prot, GIGA R, Liege, Belgium
关键词
idiopathic pulmonary fibrosis; interstitial fibrosis;
D O I
10.1136/thoraxjnl-2018-211897
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease of unknown aetiology which leads rapidly to death. As diagnosis of IPF is complex, we aimed to characterise microRNA (miRNA) content of exosomes from sputum of patients with IPF. Using miRNA quantitative PCR array, we found a substantial dysregulation of sputum exosomal miRNA levels between patients with IPF and healthy subjects and identified a unique signature of three miRNAs. Interestingly, we found a negative correlation between miR-142-3p and diffusing capacity of the lungs for carbon monoxide/alveolar volume. This is the first characterisation of miRNA content of sputum-derived exosomes in IPF that identified promising biomarkers for diagnosis and disease severity.
引用
收藏
页码:309 / 312
页数:4
相关论文
共 50 条
  • [31] The Role of Fibrocyte Derived Exosomes in the Development of Idiopathic Pulmonary Fibrosis
    Harford, J.
    Cooke, G.
    Kane, R.
    Keane, M. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S487 - S487
  • [32] Clinically Promising Biomarkers in Cystic Fibrosis Pulmonary Exacerbations
    L. Keith Scott
    Robert Toner
    Lung, 2017, 195 : 397 - 401
  • [33] Clinically Promising Biomarkers in Cystic Fibrosis Pulmonary Exacerbations
    Scott, L. Keith
    Toner, Robert
    LUNG, 2017, 195 (04) : 397 - 401
  • [34] Can biomarkers predict survival in idiopathic pulmonary fibrosis?
    Kayikci, Abdullah
    Alatas, Fusun
    Yildirim, Huseyin
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [35] Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review
    Hayton, Conal
    Terrington, Dayle
    Wilson, Andrew M.
    Chaudhuri, Nazia
    Leonard, Colm
    Fowler, Stephen J.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [36] Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review
    Hayton, Conal
    Terrington, Dayle
    Wilson, Andrew M.
    Chaudhuri, Nazia
    Leonard, Colm
    Fowler, Stephen J.
    RESPIRATORY RESEARCH, 2019, 20 (1)
  • [37] MOLECULAR BIOMARKERS IN IDIOPATHIC PULMONARY FIBROSIS AND DISEASE SEVERITY
    Crestani, B.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2013, 30 : 27 - 32
  • [38] Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review
    Conal Hayton
    Dayle Terrington
    Andrew M. Wilson
    Nazia Chaudhuri
    Colm Leonard
    Stephen J. Fowler
    Respiratory Research, 20
  • [39] Biomarkers in idiopathic pulmonary fibrosis: picking the winners for trials
    Crooks, Michael G.
    Hart, Simon P.
    LANCET RESPIRATORY MEDICINE, 2015, 3 (06): : 421 - 422
  • [40] Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
    Zhu, Weiwei
    Liu, Chunquan
    Tan, Chunting
    Zhang, Jie
    HELIYON, 2024, 10 (01)